These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18495821)

  • 1. Fractalkine in rheumatoid arthritis: a review to date.
    Murphy G; Caplice N; Molloy M
    Rheumatology (Oxford); 2008 Oct; 47(10):1446-51. PubMed ID: 18495821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt.
    Volin MV; Huynh N; Klosowska K; Chong KK; Woods JM
    Arthritis Rheum; 2007 Aug; 56(8):2512-22. PubMed ID: 17665439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.
    Silverman MD; Haas CS; Rad AM; Arbab AS; Koch AE
    Arthritis Rheum; 2007 Jun; 56(6):1817-26. PubMed ID: 17530710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fractalkine--a proinflammatory chemokine in rheumatoid arthritis].
    Blaschke S; Müller GA
    Z Rheumatol; 2008 Sep; 67(5):424-8. PubMed ID: 18633630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Repair of bone and articular destruction in rheumatoid arthritis].
    Kanbe K
    Clin Calcium; 2007 Apr; 17(4):541-5. PubMed ID: 17404483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis.
    Volin MV; Woods JM; Amin MA; Connors MA; Harlow LA; Koch AE
    Am J Pathol; 2001 Oct; 159(4):1521-30. PubMed ID: 11583978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing synovial tissue samples. What can we learn about early rheumatoid arthritis, the heterogeneity of the disease, and the effects of treatment?
    Tak PP
    J Rheumatol Suppl; 2005 Jan; 72():25-6. PubMed ID: 15660460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance.
    Szekanecz Z; Szegedi G; Koch AE
    J Investig Med; 1998 Feb; 46(2):27-41. PubMed ID: 9549225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
    Iwamoto T; Okamoto H; Toyama Y; Momohara S
    FEBS J; 2008 Sep; 275(18):4448-55. PubMed ID: 18662305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential.
    D'Haese JG; Demir IE; Friess H; Ceyhan GO
    Expert Opin Ther Targets; 2010 Feb; 14(2):207-19. PubMed ID: 20055718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synovial angiogenesis].
    Lioté F
    Rev Prat; 1993 Nov; 43(17):2239-45. PubMed ID: 7511830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of fractalkine ameliorates murine collagen-induced arthritis.
    Nanki T; Urasaki Y; Imai T; Nishimura M; Muramoto K; Kubota T; Miyasaka N
    J Immunol; 2004 Dec; 173(11):7010-6. PubMed ID: 15557198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synovial angiogenesis].
    Lioté F
    Rev Rhum Mal Osteoartic; 1991 Apr; 58(3 ( Pt 2)):51S-59S. PubMed ID: 1711712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms to form leukocyte infiltration patterns distinct between synovial tissue and fluid of rheumatoid arthritis.
    Yamamoto T; Nishiura H; Nishida H
    Semin Thromb Hemost; 1996; 22(6):507-11. PubMed ID: 9122716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines and their receptors in rheumatoid arthritis: future targets?
    Koch AE
    Arthritis Rheum; 2005 Mar; 52(3):710-21. PubMed ID: 15751074
    [No Abstract]   [Full Text] [Related]  

  • 16. Macrophages and their products in rheumatoid arthritis.
    Szekanecz Z; Koch AE
    Curr Opin Rheumatol; 2007 May; 19(3):289-95. PubMed ID: 17414958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractalkine/CX3CL1 in rheumatoid arthritis.
    Nanki T; Imai T; Kawai S
    Mod Rheumatol; 2017 May; 27(3):392-397. PubMed ID: 27484962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis.
    Odai T; Matsunawa M; Takahashi R; Wakabayashi K; Isozaki T; Yajima N; Miwa Y; Kasama T
    J Rheumatol; 2009 Jun; 36(6):1158-65. PubMed ID: 19369458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis as a target in rheumatoid arthritis.
    Koch AE
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii60-7. PubMed ID: 14532152
    [No Abstract]   [Full Text] [Related]  

  • 20. Tyrosine kinases as targets in rheumatoid arthritis.
    Tristano AG
    Int Immunopharmacol; 2009 Jan; 9(1):1-9. PubMed ID: 18848912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.